Clinical trials located in

Meldola FC

Meldola FC city is located in Italy. Currently, 1 clinical trials are being conducted in this city.

  • CT-EU-00116295

    Trial of KRT-232 and Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia

    This here clinical trial is looking at a new drug called KRT-232 for treating chronic myeloid leukemia, which is a type of blood cancer. The study aims to see if KRT-232, when taken along with other approved drugs like dasatinib or nilotinib, can help patients whose leukemia has come back or stopped responding to those other drugs.

    KRT-232 works by blocking a protein called MDM2, which normally keeps cancer cells alive. The main goals are to find the highest safe dose of KRT-232 that can be given with dasatinib or nilotinib, and to see if the combination can get patients’ leukemia under better control.

    This is an open-label study, meaning both patients and doctors know what treatment is being given. Patients must have chronic myeloid leukemia that has relapsed or become resistant to prior treatment with a tyrosine kinase inhibitor drug like dasatinib or nilotinib.

    • KRT-232
    • Dasatinib
    • Nilotinib

See more clinical trials in other cities in Italy:

.